Initial Introduction of Therapy
Publishing date: 1st October 2021
Estimated time to complete: 30 minutes
Authored by Dr Mehta, this activity covers how to develop the most appropriate treatment plans, utilizing newer therapies and combinations, for recently diagnosed or referred individuals who may have a high risk of hypoglycemia.
Learning objectives
After taking part in this module, you will be able to:
- Explain the importance of an individualized treatment plan to avoid risk of hypoglycemia.
- Describe how newer insulins and coformulations can control the risk of hypoglycemia and improve adherence.
Accreditation
In support of improving patient care, this activity has been planned and implemented by North American Center for Continuing Medical Education (NACCME) and Springer Healthcare IME. NACCME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
This activity will be certified with 0.25 AMA PRA Category 1 Credits™. Physicians should only claim the credit commensurate with the extent of their participation in the activity.
Expiration date: 1st October 2022
Translations
Transcripts are available in French, German, Italian and Spanish.
